Cardiac electrophysiologic and ultrastructural effects of platelet-activating factor and its antagonist BN 52021.
D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000818:Animals; D002462:Cell Membrane / Q000187:drug effects / Q000502:physiology; D004224:Diterpenes; D005260:Female; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D046934:Ginkgolides; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D066298:In Vitro Techniques; D007783:Lactones / Q000494:pharmacology*; D008297:Male; D008929:Mitochondria, Heart / Q000187:drug effects / Q000648:ultrastructure; D009206:Myocardium / Q000648:ultrastructure*; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors / Q000494:pharmacology*
D004224:Diterpenes; D005343:Fibrinolytic Agents; D046934:Ginkgolides; D007783:Lactones; D010972:Platelet Activating Factor; C045856:ginkgolide B